Aakash Desai, Assistant Professor and Associate Director of Phase 1 and Precision Oncology Program at the UAB O’Neal Comprehensive Cancer Center, shared a post on LinkedIn:
“American Society of Clinical Oncology (ASCO) set to showcase some innovative SCLC LCSM research, hopefully pushing boundaries in this field!
-
Improving outcomes for LCSM is a critical need!
-
Current management algorithm for SCLC and,
-
Studies being presented and where they may fit in?”
Aakash Desai highlighted the upcoming presentation of novel small cell lung cancer research at ASCO. He emphasized the need for better treatment outcomes in limited-stage SCLC and the importance of integrating new findings into clinical practice.
More posts featuring Aakash Desai.
